Vibrometry testing for carpal tunnel syndrome: a longitudinal study of daily variations.

The method of limits procedure was used to obtain 84 120Hz vibration thresholds, over a 3-month period, on four age-matched women with different levels of carpal tunnel syndrome (CTS). Each woman used a keyboard for 4 hours a day during work. Testing was conducted in a room with a temperature of 28 degrees C +/- 2 degrees C after 20 minutes acclimation. Results indicate vibration thresholds vary significantly from day to day and also demonstrate how a single vibrometry measure may falsely identify the participant's true CTS condition. Specifically, a single measure could account for a negative CTS determinations in affected wrists or positive CTS determinations in healthy wrists. Subsequent analysis revealed menses related fluid retention and day of the week increase the vibration thresholds. Analyzing the levels of fluid retention by day of the week indicates a compounding effect of the personal and occupational risk factors.

The relationship between blood alcohol concentration and crash responsibility for fatally injured drivers.

Data for 595 fatally injured drivers in Texas were analyzed using logistic regression to determine the probability of crash responsibility as a function of blood alcohol concentration (BAC). Three independent panelists rated crash responsibility on a three-point scale, based on information contained in traffic accident reports. High inter-rater reliability was noted. Panel members were in agreement 98% of the time, unanimously assigning full responsibility in 61% of the cases and no responsibility in 31% of the cases. In addition to BAC, time of day and day of week were considered as variables in the regression model. A highly significant (P less than .01) relationship was found between BAC and the probability of crash responsibility. Furthermore, results of the analysis support previous studies that noted a high rate of responsibility among fatally injured drivers, in general, even those with negative BAC test results. Such findings are of importance in evaluating driver impairment at various BACs and for determining other factors that interact with alcohol in driver fatality crashes.

Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group Study.

In a twelve-month period, 56 consecutive patients with acute leukemia, aged 15-50, were treated by administration of a 10-day continuous infusion of Ara-C in combination with adriamycin, oncovin and prednisone (10 day ADOAP). Of 50 evaluable patients, there were 39 complete remissions (78%) with a median remission duration of 71 weeks. After adjustment for age and other known prognostic factors, the complete remission rate is still 10% higher than that found using a similar regimen without adriamycin.

Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group Study.

In an 18-month period, 340 consecutive adult patients with acute leukemia were treated using a 7-day continuous infusion of Ara-C in combination with rubidazone, vincristine and prednisone (ROAP). Of 334 (96%) evaluable cases, 77% were 50 years of age or older. The complete remission (CR) rate was 51% with a standard error of 3%. After adjustment for known prognostic factors this overall CR rate is 10% higher than the predicted CR rate when compared to the last completed SWOG study which used adriamycin in combination with a similar regimen of Ara-C, vincristine, and prednisone. The CR rate in patients over 50 years of age was particularly noteworthy. Using rubidazone, the CR rate was 46.1% (116/256) compared to 37.4% (91/243) for the adriamycin study in this poorly responding age group. The median survival time achieved was 27 weeks. However, in the age groups 40-49 years and 50-59 years the median survival was 70 and 44 weeks, respectively.